Revvity, Inc. (RVTY)

USD 94.53

(1.62%)

EBITDA Summary of Revvity, Inc.

  • Revvity, Inc.'s latest annual EBITDA in 2023 was 813.25 Million USD , down -38.9% from previous year.
  • Revvity, Inc.'s latest quarterly EBITDA in 2024 Q2 was 208.76 Million USD , up 20.86% from previous quarter.
  • Revvity, Inc. reported an annual EBITDA of 1.3 Billion USD in 2022, down -31.33% from previous year.
  • Revvity, Inc. reported an annual EBITDA of 1.72 Billion USD in 2021, up 44.18% from previous year.
  • Revvity, Inc. reported a quarterly EBITDA of 59.81 Million USD for 2024 Q3, up 6.31% from previous quarter.
  • Revvity, Inc. reported a quarterly EBITDA of 208.76 Million USD for 2024 Q2, up 20.86% from previous quarter.

Annual EBITDA Chart of Revvity, Inc. (2023 - 1989)

Historical Annual EBITDA of Revvity, Inc. (2023 - 1989)

Year EBITDA EBITDA Growth
2023 813.25 Million USD -38.9%
2022 1.3 Billion USD -31.33%
2021 1.72 Billion USD 44.18%
2020 1.2 Billion USD 109.0%
2019 609.55 Million USD 15.03%
2018 518.75 Million USD 9.8%
2017 424.63 Million USD 19.08%
2016 405.95 Million USD -5.51%
2015 378.63 Million USD 21.31%
2014 322.6 Million USD -9.77%
2013 331.72 Million USD 15.46%
2012 223.23 Million USD 47.3%
2011 200.05 Million USD -16.6%
2010 267.03 Million USD 0.7%
2009 200.9 Million USD -18.03%
2008 262.64 Million USD 17.08%
2007 264.88 Million USD 23.35%
2006 219.23 Million USD -38.6%
2005 287.59 Million USD 34.54%
2004 266.58 Million USD -2.6%
2003 223.51 Million USD 24.7%
2002 156.12 Million USD -22.13%
2001 200.12 Million USD -9.46%
2000 311.28 Million USD 27.63%
1999 177.5 Million USD 197.08%
1998 82.1 Million USD -50.6%
1997 166.2 Million USD 22.3%
1996 135.9 Million USD 14.49%
1995 118.7 Million USD -29.35%
1994 168 Million USD 11.04%
1993 151.3 Million USD -1.94%
1992 154.3 Million USD -0.39%
1991 154.9 Million USD 21.39%
1990 127.6 Million USD 12.52%
1989 113.4 Million USD -2.07%

Peer EBITDA Comparison of Revvity, Inc.

Name EBITDA EBITDA Difference
Agilent Technologies, Inc. 1.67 Billion USD 51.505%
Charles River Laboratories International, Inc. 1.03 Billion USD 21.205%
Quest Diagnostics Incorporated 1.73 Billion USD 53.045%
Danaher Corporation 7.54 Billion USD 89.224%
Enzo Biochem, Inc. -8.34 Million USD 9841.89%
IQVIA Holdings Inc. 3.25 Billion USD 75.023%
Laboratory Corporation of America Holdings 1.34 Billion USD 39.732%
Mettler-Toledo International Inc. 1.18 Billion USD 31.264%
Qiagen N.V. 650.58 Million USD -25.004%
Thermo Fisher Scientific Inc. 10.8 Billion USD 92.47%
Waters Corporation 1.02 Billion USD 20.445%